FDA Inspection 647471 — Boehringer Ingelheim Pharma GmbH & Co. KG
The FDA completed an inspection of Boehringer Ingelheim Pharma GmbH & Co. KG on Feb 5, 2010 in Ingelheim am Rhein. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 5, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ingelheim am Rhein (Germany)